These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2938706)

  • 41. [Restenosis after coronary angioplasty: status in 1994].
    Vojácek J
    Vnitr Lek; 1995 May; 41(5):325-31. PubMed ID: 7653063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelets and restenosis.
    Chandrasekar B; Tanguay JF
    J Am Coll Cardiol; 2000 Mar; 35(3):555-62. PubMed ID: 10716455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans.
    Ohishi M; Ueda M; Rakugi H; Okamura A; Naruko T; Becker AE; Hiwada K; Kamitani A; Kamide K; Higaki J; Ogihara T
    Circulation; 1997 Nov; 96(10):3328-37. PubMed ID: 9396424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Increased expression of growth factors following angioplasty. Restenosis by stimulation of vascular smooth muscle cells].
    Bauriedel G
    Fortschr Med; 1992 Apr; 110(11):196. PubMed ID: 1601359
    [No Abstract]   [Full Text] [Related]  

  • 45. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty.
    Bach R; Jung F; Kohsiek I; Ozbek C; Spitzer S; Scheller B; Dyckmans J; Schieffer H
    Thromb Res; 1994; 74 Suppl 1():S55-67. PubMed ID: 8073402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical approaches to prevention of restenosis after coronary angioplasty.
    Blackshear JL; O'Callaghan WG; Califf RM
    J Am Coll Cardiol; 1987 Apr; 9(4):834-48. PubMed ID: 2951423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients.
    Nobuyoshi M; Kimura T; Ohishi H; Horiuchi H; Nosaka H; Hamasaki N; Yokoi H; Kim K
    J Am Coll Cardiol; 1991 Feb; 17(2):433-9. PubMed ID: 1991900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of antiplatelet drug use in preventing restenosis following percutaneous transluminal coronary angioplasty.
    Cox JL; Gotlieb AI
    Can J Cardiol; 1988 May; 4(4):201-10. PubMed ID: 2456140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Percutaneous transluminal coronary angioplasty].
    Malamov E; Ovanesian Kh
    Vutr Boles; 1985; 24(6):33-9. PubMed ID: 2937205
    [No Abstract]   [Full Text] [Related]  

  • 50. The mechanisms of coronary restenosis: insights from experimental models.
    Ferns GA; Avades TY
    Int J Exp Pathol; 2000 Apr; 81(2):63-88. PubMed ID: 10762439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coronary arterial rupture during coronary angioplasty.
    Saffitz JE; Rose TE; Oaks JB; Roberts WC
    Am J Cardiol; 1983 Mar; 51(5):902-4. PubMed ID: 6219571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous transluminal coronary angioplasty: current status.
    Nader JA; Maranhão V; Goldberg H
    Arq Bras Cardiol; 1985 Apr; 44(4):283-9. PubMed ID: 2936321
    [No Abstract]   [Full Text] [Related]  

  • 53. Restenosis after percutaneous transluminal coronary angioplasty--a histopathological study using autopsied hearts.
    Morimoto S; Mizuno Y; Hiramitsu S; Yamada K; Kubo N; Nomura M; Yamaguchi T; Kitazume H; Kodama K; Kurogane H
    Jpn Circ J; 1990 Jan; 54(1):43-56. PubMed ID: 2332932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Biological and cellular mechanisms of restenosis after transluminal coronary angioplasty].
    De Caterina R; Marzilli M
    G Ital Cardiol; 1991 Jan; 21(1):75-86. PubMed ID: 2055380
    [No Abstract]   [Full Text] [Related]  

  • 55. Left main coronary artery stenosis after percutaneous transluminal coronary angioplasty.
    Wayne VS; Harper RW; Pitt A
    Am J Cardiol; 1988 Feb; 61(6):459-60. PubMed ID: 2963529
    [No Abstract]   [Full Text] [Related]  

  • 56. Transluminal coronary angioplasty and early restenosis. Fibrocellular occlusion after wall laceration.
    Essed CE; Van den Brand M; Becker AE
    Br Heart J; 1983 Apr; 49(4):393-6. PubMed ID: 6219686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patients.
    Craft JA; Masci PP; Roberts MS; Brighton TA; Garrahy P; Cox S; Marsh NA
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):475-82. PubMed ID: 15311156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients.
    Waller BF; Pinkerton CA; Orr CM; Slack JD; VanTassel JW; Peters T
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):58B-70B. PubMed ID: 2016484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty. An immunocytochemical analysis of the cellular composition.
    Ueda M; Becker AE; Tsukada T; Numano F; Fujimoto T
    Circulation; 1991 Apr; 83(4):1327-32. PubMed ID: 2013150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subacute left main coronary stenosis: an unusual but serious complication of percutaneous transluminal coronary angioplasty.
    Slack JD; Pinkerton CA
    Angiology; 1985 Feb; 36(2):130-6. PubMed ID: 3161432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.